June 2008 Briefing - Allergy
Here are what the editors at HealthDay consider to be the most important developments in Allergy for June 2008. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Allergies Rampant, Poorly Treated in United Kingdom
FRIDAY, June 20 (HealthDay News) -- Allergies exert a major expense on society and appear to be rising in prevalence, yet the medical profession in the United Kingdom is handling allergies poorly, according to an editorial published in the June 21 issue of The Lancet.
Article Examines Use of 'Key Opinion Leaders' in Drug Sales
FRIDAY, June 20 (HealthDay News) -- Influential doctors known as "key opinion leaders" are paid generous fees to influence their peers to prescribe a company's drugs and may in fact be considered salespeople by the industry, according to an article in the June 21 issue of BMJ.
Combination Asthma Therapy Compared with Steroids Alone
FRIDAY, June 20 (HealthDay News) -- Salmeterol plus inhaled corticosteroids may decrease the risk for severe exacerbations, but does not appear to lower the risk of hospitalization, asthma-related deaths or intubations compared with inhaled corticosteroids alone, according to a new meta-analysis published in the July issue of the Annals of Internal Medicine.
Squirt System Best Way to Apply Nasal Dysfunction Drugs
WEDNESDAY, June 18 (HealthDay News) -- Sinonasal disease patients' poor response to treatment with corticosteroids may be due to the way therapies are applied, according to a paper published in the June 16 issue of the Archives of Otolaryngology -- Head & Neck Surgery.